Health commitment to the pharmaceutical industry’s Strategic Plan to avoid losing 8,000 million euros

“We are going to create a favourable environment”. This statement by José Manuel Miñones is the first step towards a roadmap that would highlight the key contributions of the sector Source: elmundo.es Innovation in the European pharmaceutical industry is ‘at stake’ in the new European legislation. In the midst of the regulatory reform process, which […]

Improving patient access to innovative medicines and boosting R&D and manufacturing in Spain are the main priorities of the pharmaceutical industry

“We must take advantage of the opportunity provided by the Spanish Presidency of the Council of the EU to include health, medicines and the innovative pharmaceutical industry that makes them possible among the main issues to be addressed,” said the President of Farmaindustria, Jesús Ponce, at the Annual Meeting of the Spanish Pharmaceutical Industry. “The […]

The rise of combination therapies in cancer opens up an opportunity for patients, but requires improved access procedures

Over the next five years, the number of cancer treatments consisting of more than one drug will double, with 68 authorisations expected to be granted The pharmaceutical industry stresses the importance of paying attention to the peculiarities of these combinations so that people who need them do not face additional difficulties in receiving them Source: […]

The 22nd Meeting of the Spanish Pharmaceutical Industry will focus on the reform of European legislation and its impact on Spain

The forum, organised by the Menéndez Pelayo International University (UIMP) and Farmaindustria, will be held on 7 and 8 September in Santander Patient representatives, drug authorities, experts in economics and legislation and pharmaceutical companies will participate Source: farmaindustria.es The proposed revision of the European pharmaceutical legislation published at the end of April by the European […]

The pharmaceutical industry, one of the most value-added sectors in Europe

The sector invests 41.5 billion euros in research and directly employs some 840,000 people 300 billion, exports ¤565 billion and contributes ¤175 billion to the EU-27 trade balance The current proposal to reform European pharmaceutical legislation threatens this contribution of one of the leading R&D sectors Source: farmaindustria.es The innovative pharmaceutical industry in Europe invests […]

Pharmaceutical companies set a record for investment in collaborations with the healthcare system through R&D and support for lifelong learning

Last year, the sector contributed 313 million euros for organisations and healthcare professionals to participate in research and development activities for new treatments For the eighth consecutive year, the companies adhering to Farmaindustria’s Code of Good Practice have made public their collaborations with the sector’s agents “The interaction between the pharmaceutical industry and healthcare professionals […]

Spain, a global power in clinical trials

One out of every three tests carried out in Europe takes place in Spain. Investment has grown by 5.3% annually since 2011, to almost 800 million euros Source: cincodias.elpais.com Spain continues on its path to becoming one of the global powers in clinical trials. In fact, it is the second country preferred by the pharmaceutical […]

“We must bring clinical trials closer to the patient’s home, and for this, research in primary care is vital”

The associate director of Clinical and Translational Research at Farmaindustria, Amelia Martín Uranga, explained at a forum organised by the POP that work is already underway on a document of recommendations to promote these studies at the primary care level She demanded more centres in which to carry out clinical research so that more and […]

“Difficulties in access to orphan drugs in Spain are detrimental to patients, the healthcare system and pharmaceutical companies”

The director of Farmaindustria’s Access Department, Isabel Pineros, explains the situation of these drugs in Spain at a conference organised by the Kronos Foundation, the Hospital Clínico San Carlos and the Royal National Academy of Pharmacy Treatments for rare diseases account for one in four approvals by the European Medicines Agency in 2022 In Spain, […]

XVI ANNUAL CONFERENCE OF BIOMEDICAL RESEARCH TECHNOLOGY PLATFORMS

On 23 May, part of the Distefar team attended the biomedical research technology platform. The opening was a conference by Juan José Vaquero, entitled “Strategy for greater public-private collaboration in research”.  He highlighted Spain’s important work in scientific production, which according to the CYD Foundation is ranked 11th, in contradiction to Innovation, where we are […]